C4 Therapeutics Inc (NASDAQ: CCCC) is -3.89% lower on its value in year-to-date trading and has touched a low of $1.06 and a high of $11.88 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CCCC stock was last observed hovering at around $5.56 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $5.43, the stock is -11.28% and -11.82% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.75 million and changing -2.34% at the moment leaves the stock -16.05% off its SMA200. CCCC registered 219.41% gain for a year compared to 6-month loss of -31.27%. The firm has a 50-day simple moving average (SMA 50) of $6.137 and a 200-day simple moving average (SMA200) of $6.4703.
The stock witnessed a -9.65% gain in the last 1 month and extending the period to 3 months gives it a 19.34%, and is -13.26% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.38% over the week and 10.06% over the month.
C4 Therapeutics Inc (CCCC) has around 145 employees, a market worth around $376.52M and $29.38M in sales. Profit margin for the company is -367.17%. Distance from 52-week low is 412.26% and -54.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.80%).
The EPS is expected to grow by 46.93% this year
149.0 institutions hold shares in C4 Therapeutics Inc (CCCC), with institutional investors hold 100.15% of the company’s shares. The shares outstanding are 60.47M, and float is at 57.36M with Short Float at 20.79%. Institutions hold 88.48% of the Float.
The top institutional shareholder in the company is LYNX1 CAPITAL MANAGEMENT LP with over 6.88 million shares valued at $31.79 million. The investor’s holdings represent 9.9993 of the CCCC Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 4.88 million shares valued at $22.54 million to account for 7.0891 of the shares outstanding. The other top investors are WASATCH ADVISORS LP which holds 4.85 million shares representing 7.0442 and valued at over $22.39 million, while BLACKROCK INC. holds 6.6146 of the shares totaling 4.55 million with a market value of $21.03 million.
